logo
15:51 May 29

Kilitch Drugs(I) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
182.39
+0.37 (+0.20%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Kilitch Drugs(I) Ltd. Financials

Kilitch Drugs(I) Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
182.39
+0.37 (+0.20%)
15:51 May 29
Quality
image/svg+xml

32/100
Low Financial Strength

Valuation
image/svg+xml

42/100
Mid Valuation

Technical

54/100
Technically Neutral

Strength

11

Weakness

2

Opportunity

0

Threats

0

10.78 %

ROE %

6.59 %

ROA %

8.63

EPS

79.99

BVPS

12.81 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
114.23 139.6 154.37 198.32 235.47
Operating Expenses +
103.86 122.03 130.22 166.85 198.88
Raw Material
65.48 74.53 79.08 105.75 125.07
Increase Decrease in Cost
-0.05 0.23 -0.12 -1.17 1.07
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
6.18 11.73 10.01 11.32 14.31
Miscellaneous Expenses
32.25 35.54 41.25 50.95 58.43
Operating Profit
10.37 17.57 24.15 31.47 36.59
Other Income
2.91 2.92 4.48 11.16 11.24
Depreciation
2.47 3.55 3.35 3.11 3.62
Interest
1.2 4.92 5.93 5.04 5.56
Profit before tax and exceptio..
9.61 12.01 19.35 34.47 38.65
Exceptional Items
0 0 0 0 0
PBT
9.61 12.01 19.35 34.47 38.65
Provision for Taxation
3.4 3.73 5.78 9.53 9.15
Net Profit
6.21 8.28 13.58 24.94 29.5
NET Profit after MI
7.37 10.45 14.6 26.7 30.17
EPS
4.73 6.71 9.17 16.6 8.91
Operating Profit Margin (%)
9.08 12.59 15.64 15.87 15.54
Net Profit Margin (%)
6.45 7.49 9.46 13.46 12.81

Kilitch Drugs(I) Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 63.80 63.80 63.80 69.20 69.20 69.20
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 36.20 36.20 36.20 30.80 30.80 30.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: